Eramet S.a.'s current cash is $1.2B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest current cash for ERMAF is $1.2B as of June 2026. That compares with $600M in the prior-year period — up 106.6% year over year. Investors often review this figure alongside Eramet S.a.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, ERMAF's current cash moved from $600M to $1.2B — a 106.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Eramet S.a.'s operating scale or balance-sheet position.
A current cash figure of $1.2B for ERMAF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting ERMAF's current cash ($1.2B), review year-over-year change from $600M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.